Chronic Disease Modeling DOI
WayWay M. Hlaing, Yiliang Zhu

Elsevier eBooks, Год журнала: 2024, Номер unknown, С. 405 - 413

Опубликована: Июнь 25, 2024

Язык: Английский

Higher risk of adverse cardiovascular outcomes in females with type 2 diabetes Mellitus: an Umbrella review of systematic reviews DOI
Clyve Yu Leon Yaow, Bryan Chong, Yip Han Chin

и другие.

European Journal of Preventive Cardiology, Год журнала: 2023, Номер 30(12), С. 1227 - 1235

Опубликована: Апрель 26, 2023

Previous studies have shown that females with type 2 diabetes mellitus (T2DM) may excess mortality risk compared to their male counterparts. An important next step address the high global burden of T2DM and cardiovascular disease (CVD) is an umbrella review summarize data on sex differences in outcomes for patients assess strength evidence observed.

Язык: Английский

Процитировано

16

Association between the triglyceride glucose index and low skeletal muscle mass: a cross-sectional study DOI Creative Commons
Zhenzhen Li, Tong Xiang, Yao Ma

и другие.

BMJ Open, Год журнала: 2024, Номер 14(1), С. e077484 - e077484

Опубликована: Янв. 1, 2024

Triglyceride glucose (TyG) represents a consistent surrogate biomarker and index of insulin resistance (IR), IR has also been linked to skeletal muscle mass loss (SMM-L). Here, we evaluated the association between SMM-L TyG (TyGi).

Язык: Английский

Процитировано

5

Effects of probiotics, prebiotics and synbiotics on anthropometric, cardiometabolic and inflammatory markers: An umbrella review of meta-analyses DOI

Yu Qing Jolene Teo,

Bryan Chong,

Rou Yi Soong

и другие.

Clinical Nutrition, Год журнала: 2024, Номер 43(6), С. 1563 - 1583

Опубликована: Май 10, 2024

Язык: Английский

Процитировано

5

The prognostic value of metabolic dysfunction‐associated steatotic liver disease in acute myocardial infarction: A propensity score‐matched analysis DOI
Gwyneth Kong,

Grace Cao,

Jaycie Koh

и другие.

Diabetes Obesity and Metabolism, Год журнала: 2024, Номер 26(8), С. 3328 - 3338

Опубликована: Май 23, 2024

Abstract Aim Patients with metabolic dysfunction‐associated steatotic liver disease (MASLD) are at increased risk of incident cardiovascular disease. However, the clinical characteristics and prognostic importance MASLD in patients presenting acute myocardial infarction (AMI) have yet to be examined. Methods This study compared outcomes without AMI a tertiary centre Singapore. was defined as hepatic steatosis, least one five criteria. Hepatic steatosis determined using Steatosis Index. Propensity score matching performed adjust for age sex. The Kaplan‐Meier curve constructed long‐term all‐cause mortality. Cox regression analysis used investigate independent predictors Results In this 4446 AMI, 2223 were matched propensity scores. mean follow‐up duration 3.4 ± 2.4 years. group had higher rates obesity, diabetes chronic kidney than their counterparts. early excess mortality (6.8% vs. 3.6%, p < .001) 30 days, unfavourable sustained (18.3% 14.5%, = those MASLD. After adjustment, remained independently associated (hazard ratio 1.330, 95% confidence interval 1.106‐1.598, .002). Conclusion embodies burden dysfunction is an predictor population. Its identification may beneficial stratification provide therapeutic targets secondary preventive strategies AMI.

Язык: Английский

Процитировано

5

Chronic Disease Modeling DOI
WayWay M. Hlaing, Yiliang Zhu

Elsevier eBooks, Год журнала: 2024, Номер unknown, С. 405 - 413

Опубликована: Июнь 25, 2024

Язык: Английский

Процитировано

5